Menu
Back to User profile » Dr Eva Blozik
Papers published by Dr Eva Blozik:
Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA
Neuropsychiatric Disease and Treatment 2021, 17:1021-1034
Published Date: 12 April 2021
Trends in Micronutrient Laboratory Testing in Switzerland: A 7-Year Retrospective Analysis of Healthcare Claims Data
Huber CA, Nagler M, Rosemann T, Blozik E, Näpflin M, Markun S
International Journal of General Medicine 2020, 13:1341-1348
Published Date: 2 December 2020
Continuity of Care in Swiss Cancer Patients Using Claims Data
Blozik E, Bähler C, Näpflin M, Scherer M
Patient Preference and Adherence 2020, 14:2253-2262
Published Date: 18 November 2020
Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists
Huber CA, Agosti R, Näpflin M, Blozik E
Journal of Pain Research 2019, 12:2211-2221
Published Date: 19 July 2019
Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer
Szucs TD, Szillat KP, Blozik E
Pharmacogenomics and Personalized Medicine 2018, 11:67-69
Published Date: 23 April 2018
Intensity of treatment in Swiss cancer patients at the end-of-life
Bähler C, Signorell A, Blozik E, Reich O
Cancer Management and Research 2018, 10:481-491
Published Date: 15 March 2018
Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015
Blozik E, Rapold R, Eichler K, Reich O
Neuropsychiatric Disease and Treatment 2017, 13:2737-2745
Published Date: 1 November 2017
How does hospitalization affect continuity of drug therapy: an exploratory study
Blozik E, Signorell A, Reich O
Therapeutics and Clinical Risk Management 2016, 12:1277-1283
Published Date: 22 August 2016